Key Segmentation
By Technology
-
Polymerase Chain Reaction (PCR)
-
Next-Generation Sequencing (NGS)
-
Microarrays
-
In-Situ Hybridization (FISH / CISH)
-
Sanger Sequencing & Others
By Application
-
Oncology (Cancer Diagnostics)
-
Infectious Disease Testing
-
Genetic Disorder Screening
-
Prenatal & Newborn Screening
-
Forensic & Ancestry Testing
-
Others
By End User
-
Hospitals & Clinics
-
Diagnostic Laboratories
-
Pharmaceutical & Biotechnology Companies
-
Academic & Research Institutes
-
Forensic Laboratories
By Test Type
-
Diagnostic Testing
-
Carrier Testing
-
Predictive & Presymptomatic Testing
-
Prenatal Testing
-
Newborn Screening
By Sample Type
-
Blood Samples
-
Saliva Samples
-
Tissue Samples
-
Buccal Swabs
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: North America dominated with a 45.04% share in 2025, while Asia-Pacific is the fastest-growing region, expected to expand at a CAGR of 9.19% during 2026–2035.
Ans: Polymerase Chain Reaction (PCR) dominated with a 38.55% share in 2025, while Next-Generation Sequencing (NGS) are also projected to grow at the fastest CAGR of 9.34% during 2026–2035.
Ans: Growth is driven by rising prevalence of genetic and chronic diseases, increasing adoption of precision medicine, and rapid expansion of next-generation sequencing (NGS) and PCR-based diagnostic technologies.
Ans: The market is valued at USD 19.24 Billion in 2025 and is projected to reach USD 40.84 Billion by 2035.
Ans: The DNA Diagnostics Market is projected to grow at a CAGR of 8.04% during 2026–2035.